Ex-Novartis boss shines as CEO

Posted 23 May 2024 AM

In less than five months at the helm of Starpharma, Cherly Maley, has established a pathway to increase the company's revenue by "accelerating commercial opportunities" and "building stronger brands" for its existing products.

The Melbourne-based pharma is the only company to have commercialised dendrimer-based products, which includes antiviral nasal spray Viraleze and bacterial vaginosis treatment VivaGel, both based on SPL7013, a novel dendrimer with antimicrobial properties. 

To see the whole article, please login